Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults With Alpha-1 Antitrypsin Deficiency–Associated Liver Disease Post author:GIBoardReview.com Post published:May 27, 2026 Post category:Society Guidelines You Might Also Like Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases—A Clinical Practice Update: Commentary January 1, 2019 ACG Clinical Guideline: Management of Irritable Bowel Syndrome December 14, 2020 AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis February 28, 2023
Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases—A Clinical Practice Update: Commentary January 1, 2019
AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis February 28, 2023
